Mark Owyong

497 total citations
10 papers, 270 citations indexed

About

Mark Owyong is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Mark Owyong has authored 10 papers receiving a total of 270 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Immunology, 4 papers in Oncology and 2 papers in Molecular Biology. Recurrent topics in Mark Owyong's work include Immune Cell Function and Interaction (4 papers), Immune cells in cancer (2 papers) and Vascular Tumors and Angiosarcomas (1 paper). Mark Owyong is often cited by papers focused on Immune Cell Function and Interaction (4 papers), Immune cells in cancer (2 papers) and Vascular Tumors and Angiosarcomas (1 paper). Mark Owyong collaborates with scholars based in United States, United Kingdom and Netherlands. Mark Owyong's co-authors include Vicki Plaks, Gizem Efe, Zena Werb, Chih‐Yang Wang, Renske J.E. van den Bijgaart, Charlotte D. Koopman, Charlene Lin, Niwen Kong, Mark B. Headley and Irit Sagi and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Immunity and Oncotarget.

In The Last Decade

Mark Owyong

10 papers receiving 267 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark Owyong United States 8 122 107 79 73 43 10 270
Xuqing Shen China 7 126 1.0× 104 1.0× 72 0.9× 65 0.9× 27 0.6× 11 257
Zihang Ling China 8 153 1.3× 96 0.9× 101 1.3× 48 0.7× 29 0.7× 13 291
Wenbo Yang China 9 152 1.2× 144 1.3× 87 1.1× 58 0.8× 32 0.7× 15 305
Angelica Pace Italy 8 114 0.9× 77 0.7× 69 0.9× 90 1.2× 30 0.7× 10 252
Dimitris C. Kanellis Denmark 10 209 1.7× 85 0.8× 88 1.1× 62 0.8× 31 0.7× 14 323
Corinna U. Brehm Germany 4 147 1.2× 170 1.6× 86 1.1× 97 1.3× 39 0.9× 6 326
Pengfei Sun China 13 178 1.5× 73 0.7× 108 1.4× 70 1.0× 40 0.9× 24 328
Allan D. Burrows Australia 7 133 1.1× 126 1.2× 59 0.7× 98 1.3× 33 0.8× 10 287
Zhizhong Wei China 10 160 1.3× 84 0.8× 67 0.8× 105 1.4× 19 0.4× 17 312
Christine Pich-Bavastro Switzerland 11 159 1.3× 101 0.9× 109 1.4× 79 1.1× 44 1.0× 16 325

Countries citing papers authored by Mark Owyong

Since Specialization
Citations

This map shows the geographic impact of Mark Owyong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Owyong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Owyong more than expected).

Fields of papers citing papers by Mark Owyong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Owyong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Owyong. The network helps show where Mark Owyong may publish in the future.

Co-authorship network of co-authors of Mark Owyong

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Owyong. A scholar is included among the top collaborators of Mark Owyong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Owyong. Mark Owyong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Mujal, Adriana M., Mark Owyong, Endi K. Santosa, et al.. (2025). Splenic TNF-α signaling potentiates the innate-to-adaptive transition of antiviral NK cells. Immunity. 58(3). 585–600.e6. 5 indexed citations
2.
Sheppard, Sam, Katja Srpan, Rebecca B. Delconte, et al.. (2024). Fatty acid oxidation fuels natural killer cell responses against infection and cancer. Proceedings of the National Academy of Sciences. 121(11). e2319254121–e2319254121. 30 indexed citations
3.
Delconte, Rebecca B., Mark Owyong, Endi K. Santosa, et al.. (2024). Fasting reshapes tissue-specific niches to improve NK cell-mediated anti-tumor immunity. Immunity. 57(8). 1923–1938.e7. 23 indexed citations
4.
Hagerling, Catharina, Mark Owyong, Chih‐Yang Wang, et al.. (2020). LGR5 in breast cancer and ductal carcinoma in situ: a diagnostic and prognostic biomarker and a therapeutic target. BMC Cancer. 20(1). 542–542. 28 indexed citations
5.
Owyong, Mark, Jonathan Chou, Renske J.E. van den Bijgaart, et al.. (2019). MMP9 modulates the metastatic cascade and immune landscape for breast cancer anti-metastatic therapy. Life Science Alliance. 2(6). e201800226–e201800226. 78 indexed citations
6.
Owyong, Mark, et al.. (2018). Overcoming Barriers of Age to Enhance Efficacy of Cancer Immunotherapy: The Clout of the Extracellular Matrix. Frontiers in Cell and Developmental Biology. 6. 19–19. 22 indexed citations
7.
Owyong, Mark, Niloufar Hosseini-Nassab, Gizem Efe, et al.. (2017). Cancer Immunotherapy Getting Brainy: Visualizing the Distinctive CNS Metastatic Niche to Illuminate Therapeutic Resistance. Drug Resistance Updates. 33-35. 23–35. 16 indexed citations
8.
Sun, Zhengda, Chih‐Yang Wang, Devon A. Lawson, et al.. (2017). Single-cell RNA sequencing reveals gene expression signatures of breast cancer-associated endothelial cells. Oncotarget. 9(13). 10945–10961. 42 indexed citations
9.
Wang, Bo, Mark Owyong, Fernando F. Corrales‐Medina, et al.. (2016). Neonatal kaposiform hemangioendothelioma of the spleen associated with Kasabach-Merritt phenomenon. Journal of Pediatric Surgery. 51(6). 1047–1050. 6 indexed citations
10.
Shao, Hongwei, Long Cai, Mecker G. Möller, et al.. (2016). Notch1—WISP-1 axis determines the regulatory role of mesenchymal stem cell-derived stromal fibroblasts in melanoma metastasis. Oncotarget. 7(48). 79262–79273. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026